MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 14.81 Billion KRW | -85.99% |
| 2022 | 105.7 Billion KRW | 454.69% |
| 2021 | 19.05 Billion KRW | -40.83% |
| 2020 | 32.2 Billion KRW | 36.23% |
| 2019 | 23.64 Billion KRW | 154.8% |
| 2018 | 9.27 Billion KRW | 41.98% |
| 2017 | 6.53 Billion KRW | -7.53% |
| 2016 | 7.06 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -11.22 Billion KRW | -135.47% |
| 2024 Q1 | 31.63 Billion KRW | 113.58% |
| 2023 Q1 | 90.29 Billion KRW | -14.58% |
| 2023 Q4 | 14.81 Billion KRW | -40.51% |
| 2023 Q3 | 24.9 Billion KRW | -51.23% |
| 2023 Q2 | 51.05 Billion KRW | -43.46% |
| 2023 FY | 14.81 Billion KRW | -85.99% |
| 2022 Q2 | 68.69 Billion KRW | 178.47% |
| 2022 Q1 | 24.67 Billion KRW | 29.45% |
| 2022 Q3 | 98.35 Billion KRW | 43.17% |
| 2022 Q4 | 105.7 Billion KRW | 7.47% |
| 2021 Q4 | 19.05 Billion KRW | -6.83% |
| 2021 Q3 | 20.45 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Co., Ltd. | -46.18 Billion KRW | 132.077% |
| iNtRON Biotechnology, Inc. | -40.58 Billion KRW | 136.502% |
| BINEX Co., Ltd. | 45.34 Billion KRW | 67.332% |
| Bioneer Corporation | -3.9 Billion KRW | 479.097% |
| Anterogen.Co.,Ltd. | 8.35 Billion KRW | -77.379% |
| CrystalGenomics, Inc. | 8.99 Billion USD | -64.752% |
| Helixmith Co., Ltd | -24.42 Billion KRW | 160.65% |
| Chabiotech Co.,Ltd. | 388.94 Billion KRW | 96.191% |
| Medy-Tox Inc. | 49.58 Billion KRW | 70.123% |
| Peptron, Inc. | 4.86 Billion KRW | -204.281% |
| Amicogen, Inc. | 125.26 Billion KRW | 88.173% |
| Genexine, Inc. | 61.39 Billion KRW | 75.871% |
| HLB Therapeutics Co.,Ltd. | -13.68 Billion KRW | 208.238% |
| LegoChem Biosciences, Inc. | -56.05 Billion KRW | 126.429% |
| ALTEOGEN Inc. | 53.56 Billion KRW | 72.346% |
| PharmaResearch Co., Ltd. | -32.93 Billion KRW | 144.976% |
| SillaJen, Inc. | -13.89 Billion KRW | 206.642% |
| JETEMA, Co., Ltd. | 84.27 Billion KRW | 82.422% |
| OliX Pharmaceuticals,Inc | 27.37 Billion KRW | 45.883% |
| Genomictree Inc. | -43.43 Billion KRW | 134.107% |
| MedPacto, Inc. | -64 Billion KRW | 123.147% |
| D&D Pharmatech | -7.5 Billion KRW | 297.319% |
| EASY BIO,Inc. | 53.21 Billion KRW | 72.159% |
| GI Innovation, Inc. | -4.82 Billion KRW | 407.191% |